Ciba. Chiron may terminate this Agreement in its entirety upon ninety (90) days prior written notice; provided, however, that such notice of termination may not be given prior to three (3) months after the Effective Date. Notwithstanding the foregoing, if the Fragmentation and Embolization Study fails to meet the Study Criteria, as set forth in Section 3.3.1, Ciba/Chiron shall have the right to terminate this Agreement upon thirty (30) days prior written notice as set forth in Section 3.3.1(c).
Appears in 3 contracts
Sources: Collaboration and License Agreement (Focal Inc), Collaboration and License Agreement (Focal Inc), Collaboration and License Agreement (Focal Inc)